Medicinal Products

AMOROLFIN BGR 5%

Generic drug from Loceryl
Therapeutic class: Dermatology
active ingredients: Amorolfine
laboratory: Biogaran

Medicated nail polish
bottle of 250 ml
All forms

Indication

Treatment of moderate distal and lateral subungual onychomycosis, caused by dermatophytes, yeasts or molds, affecting no more than two nails in adults.

Dosage AMOROLFINE BGR 5% medicated nail polish 250 ml bottle

Treatment of moderate distal and lateral subungual onychomycosis, caused by dermatophytes, yeasts or molds, affecting no more than two nails in adults.

Against indications

History of allergy to one of the components.

Adverse effects Amorolfine Bgr

Reactions to the product are rare.

Skin and subcutaneous tissues:

Since marketing have been reported:

· Ungual anomalies (eg nail dyschromia, brittle nail, fragile nail). However, these reactions may be directly related to onychomycosis.

· Skin burning sensations and contact dermatitis.

Reporting of suspected adverse reactions

The reporting of suspected adverse reactions after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals declare any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article